A Study to Evaluate JYP0061 Tablets in Patients With Moderate-to-severe Atopic Dermatitis
Status:
Not yet recruiting
Trial end date:
2025-02-10
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to evaluate the efficacy and safety of JYP0061 in adult
patients with moderate-to-severe atopic dermatitis. The main questions it aims to answer are:
- The efficacy of JYP0061 in treating adult patients with moderate-to-severe atopic
dermatitis.
- The safety profile of JYP0061 when administered to adult patients with
moderate-to-severe atopic dermatitis.
Participants will:
- Be treated with either a low-dose or high-dose of JYP0061.
- Undergo efficacy and safety evaluations as stipulated in the trial protocol.